4.8 Review

Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS

Journal

NEURON
Volume 101, Issue 6, Pages 1057-1069

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2019.02.032

Keywords

-

Categories

Funding

  1. National Institutes of Health/National Institute of Neurological Disorders and Stroke [R35NS097273, P01NS084974, U54NS100693]
  2. Mayo Clinic Foundation
  3. Amyotrophic Lateral Sclerosis Association
  4. Robert Packard Center for ALS Research at Johns Hopkins
  5. Target ALS Foundation

Ask authors/readers for more resources

Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disorder that orchestrates an attack on the motor nervous system that is unrelenting. Recent discoveries into the pathogenic consequences of repeat expansions in C9ORF72, which are the most common genetic cause of ALS, combined with the identification of new genetic mutations are providing novel insight into the underlying mechanism(s) that cause ALS. In particular, the myriad of functions linked to ALS-associated genes have collectively implicated four main pathways in disease pathogenesis, including RNA metabolism and translational biology; protein quality control; cytoskeletal integrity and trafficking; and mitochondrial function and transport. Through the identification of common disease mechanisms on which multiple ALS genes converge, key targets for potential therapeutic intervention are highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available